Hyperfine, Inc.

Equities

HYPR

US44916K1060

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
0.82 ^USD	-2.96%		-3.53%	-26.79%

Apr. 17	Hyperfine, Inc. Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in Care PMR Study	CI
Mar. 22	Wells Fargo Trims Hyperfine's Price Target to $1.60 From $2.10, Keeps Equalweight Rating	MT

Hyperfine, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

March 21, 2024 at 04:05 pm EDT

Hyperfine, Inc. provided earnings guidance for the first quarter and full year 2024. For the quarter, the company expects revenue to be over $3 million.

For the full year, the company expects revenue to be $12 million to $15 million.

Latest news about Hyperfine, Inc.

Hyperfine, Inc. Enroll First Alzheimer's Patients Receiving Amyloid-Targeting Therapy in Care PMR Study	Apr. 17	CI
Wells Fargo Trims Hyperfine's Price Target to $1.60 From $2.10, Keeps Equalweight Rating	Mar. 22	MT
B. Riley Trims Hyperfine's PT to $1.30 From $1.70 After 'Disappointing' Q4 2023 Sales, 2024 Guidance; Maintains Buy Rating	Mar. 22	MT
Transcript : Hyperfine, Inc., Q4 2023 Earnings Call, Mar 21, 2024	Mar. 21
Earnings Flash (HYPR) HYPERFINE Posts Q4 Revenue $2.7M	Mar. 21	MT
Hyperfine, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
Hyperfine, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Hyperfine, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024	Mar. 21	CI
Hyperfine, Inc. and Athletic Heart Cardiac and Metabolic Testing, Llc Announce Collaboration to Bring Portable Brain Imaging Screening to Current and Former Professional Athletes	Feb. 21	CI
Hyperfine, Inc. Launches AI-Powered Brain Imaging Software for Enhanced Image Quality and Ease of Use	Jan. 09	CI
Jefferies Starts Hyperfine With Hold Rating	Nov. 30	MT
Transcript : Hyperfine, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
Hyperfine, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Earnings Flash (HYPR) HYPERFINE Reports Q3 Revenue $2.3M, vs. Street Est of $2.95M	Nov. 09	MT
Hyperfine, Inc. Provides Earnings Guidance for the Full Year 2023	Nov. 09	CI
Investors Look Ahead to FOMC Meeting, Earnings Reports as US Futures Trend Higher Monday	23-10-30	MT
Top Premarket Decliners	23-10-30	MT
Hyperfine Says US FDA Clears Updated AI-Powered Swoop System Software	23-10-09	MT
Hyperfine, Inc. Announces the Termination of Khan Siddiqui as Chief Medical Officer and Chief Strategy Officer	23-10-03	CI
Hyperfine, Inc.(NasdaqGM:HYPR) added to S&P Global BMI Index	23-09-18	CI
B. Riley Lifts Hyperfine's Price Target to $3.50 From $2.50 After Higher-Than-Expected Q2 Results, Keeps Buy Rating	23-08-15	MT
Transcript : Hyperfine, Inc., Q2 2023 Earnings Call, Aug 14, 2023	23-08-14
Hyperfine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Earnings Flash (HYPR) HYPERFINE Reports Q2 Revenue $3.4M, vs. Street Est of $2.8M	23-08-14	MT
Hyperfine, Inc. Provides Earnings Guidance for the Full Year 2023	23-08-14	CI

Chart Hyperfine, Inc.

Duration

Period

More charts

Company Profile

Hyperfine, Inc. is a health technology company. The Company provides a Swoop Portable Magnetic Resonance Imaging System (Swoop system), which is a portable magnetic resonance imaging (MRI) system capable of providing neuroimaging at the point of care. Its Swoop system produces images at a lower magnetic field strength than conventional MRI scanners. The Swoop system is a portable, ultra-low-field (ULF) MRI device for producing images that display the internal structures of the head where full diagnostic examination is not clinically practical. MRI is used in various clinical settings for medical diagnosis, the staging of disease, and follow-up treatment. It has designed Swoop system to address an unmet need in point-of-care medical imaging through a combination of hardware and artificial intelligence (AI)-powered software services. The Companyâs system operates from a Wi-Fi-capable tablet and integrates with picture archiving and communication systems (PACS).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-07 - International Society for Magnetic Resonance in Medicine Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Hyperfine, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.82 USD

Average target price

1.3 USD

Spread / Average Target

+58.54%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

	1st Jan change	Capi.
HYPERFINE, INC.	-26.79%	59.05M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	-3.22%	15.01B
IRAY TECHNOLOGY COMPANY LIMITED	-36.36%	2.91B
SONOSCAPE MEDICAL CORP.	-12.35%	2.46B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	-12.00%	1.46B
CORETAG, INC.	-.--%	1.12B
NANO-X IMAGING LTD.	+40.97%	519M
GUERBET	+90.51%	499M
DETECTION TECHNOLOGY OYJ	+12.77%	243M
VIEWORKS CO., LTD.	+1.30%	183M

Medical Imaging Systems